Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Xiaoling Wang,Xunbin Wei

DOI: https://doi.org/10.1364/acpc.2016.af3k.2

2016-01-01

Abstract:An in vivo flow cytometer is used to monitoring circulating tumor cells. The counting of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of tumor metastasis.

What problem does this paper attempt to address?

Monitoring Hepatocellular Carcinoma Metastasis by in Vivo Flow Cytometer

Yan Li,Jin Guo,Guangda Liu,Chen Wang,Zhengqin Gu,Xunbin Wei

DOI: https://doi.org/10.1117/12.843459

2010-01-01

Abstract:A recently developed "in vivo flow cytometer" and optical imaging are used to assess liver tumor cell spreading and the circulation kinetics of liver tumor cells. The in vivo flow cytometer has the capability to detect and quantify the number and flow characteristics of fluorescently labeled cells in vivo continuously. The depletion rate of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of liver tumor metastasis. A real-time quantitative monitoring of circulating liver tumor cells by the in vivo flow cytometer will help assess the effectiveness of the potential therapeutic interventions.
A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

Xunbin Wei,Jian Zhou,Xi Zhu,Xinrong Yang,Ping Yang,Qiyan Wang

DOI: https://doi.org/10.1007/978-1-4939-7144-2_21

2017-01-01

Abstract:The quantification of circulating tumor cells (CTCs) has been considered a potentially powerful tool in cancer diagnosis and prognosis, as CTCs have been shown to appear very early in cancer development. Great efforts have been made to develop methods that were less invasive and more sensitive to detect CTCs earlier. There is growing evidence that CTC clusters have greater metastatic potential than single CTCs. Therefore, the detection of CTC clusters is also important. This chapter is aimed to introduce a noninvasive technique for CTCs detection named in vivo flow cytometry (IVFC), which has been demonstrated to be capable of monitoring CTCs dynamics continuously. Furthermore, IVFC could be helpful for CTC cluster enumeration.
Monitoring circulating tumor cells in vivo by a confocal microscopy system

Yuhao Hu,Wanyi Tang,Pan Cheng,Quanyu Zhou,Xiaoying Tian,Xunbin Wei,Hao He

DOI: https://doi.org/10.1002/cyto.a.23702

Abstract:Circulating tumor cells (CTCs) play a key role in cancer metastasis but are very difficult to detect. in vivo monitoring CTCs has been recognized as an important technique for cancer research and clinical diagnosis. Recently, a noninvasive method, in vivo flow cytometry (IVFC) has been developed to enable continuous, real-time, and long-duration detection of CTCs in animal models by detecting CTC fluorescence in blood vessels excited by lasers. In this study, we present a simple optical scheme for direct noninvasive CTC detection using confocal microscopes. We demonstrate that line scanning of confocal microscopy can provide effective and quantitative CTC detection in live mice during cancer development. Rare CTC signals can be acquired at the early stage of the tumor development after implantation of subcutaneous tumor and monitored continuously to the end. Signals from CTC clusters can also be acquired and distinguished from single CTCs. Our results suggest confocal microscopy is a simple and reliable method for biologists and doctors to use for cancer research. © 2018 International Society for Advancement of Cytometry.
In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

I Georgakoudi,N Solban,J Novak,WL Rice,XB Wei,T Hasan,CP Lin

DOI: https://doi.org/10.1364/bio.2004.thc6

2004-01-01

Abstract:The fate of circulating tumor cells is an important determinant of their ability to form distant metastasis. Here, we demonstrate the use of in vivo flow cytometry as a powerful new method for detecting quantitatively circulating cancer cells. We specifically examine the circulation kinetics of two prostate cancer cell lines with different metastatic potential in mice and rats. We find that the cell line and the host environment affect the circulation kinetics of prostate cancer cells, with the intrinsic cell line properties determining the initial rate of cell depletion from the circulation and the host affecting cell circulation at later time points.
Studying Cancer Metastasis Potential by In-Vivo Flow Cytometry and Imaging

Guangda Liu,Jin Guo,Yan Li,Zhichao Fan

DOI: https://doi.org/10.1109/acp.2010.5682512

2010-01-01

Abstract:An in vivo flow cytometer and optical imaging are used to assess tumor cell spreading. The depletion rate of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of tumor metastasis.
Monitoring Circulating Apoptotic Cells by In-Vivo Flow Cytometry

Xunbin Wei,Yuan Tan,Yun Chen,Li Zhang,Yan Li,Guangda Liu,Bin Wu,Chen Wang

DOI: https://doi.org/10.1117/12.762574

2008-01-01

Abstract:Chemotherapies currently constitute one main venue of cancer treatment. For a large number of adult and elderly patients, however, treatment options are poor. These patients may suffer from disease that is resistant to conventional chemotherapy or may not be candidates for curative therapies because of advanced age or poor medical conditions. To control disease in these patients, new therapies must be developed that are selectively targeted to unique characteristics of tumor cell growth and metastasis. A reliable early evaluation and prediction of response to the chemotherapy is critical to its success. Chemotherapies induce apoptosis in tumor cells and a portion of such apoptotic cancer cells may be present in the circulation. However, the fate of circulating tumor cells is difficult to assess with conventional methods that require blood sampling. We report the in situ measurement of circulating apoptotic cells in live animals using in vivo flow cytometry, a novel method that enables real-time detection and quantification of circulating cells without blood extraction. Apoptotic cells are rapidly cleared from the circulation with a half-life of ~10 minutes. Real-time monitoring of circulating apoptotic cells can be useful for detecting early changes in disease processes, as well as for monitoring response to therapeutic intervention.
In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Zhichao Fan,Xunbin Wei

DOI: https://doi.org/10.1515/plm-2012-0043

2013-01-01

Photonics and Lasers in Medicine

Abstract:AbstractOptical methods have revolutionized medical diagnoses, therapies and research, and have penetrated many medical disciplines for example, tumor diagnosis and treatment. Tumor recurrence and metastasis are the major obstacles for long-term survival in cancer. The metastasis is reported to be correlated with the presence of circulating tumor cells (CTCs) in the vasculature as a consequence of either advanced tumor growth and invasion, or a therapeutic intervention. Thus, CTCs are considered to be important biomarkers for cancer progress and prognosis. The quantification of CTCs is an emerging tool used to diagnose, stratify and monitor patients with metastatic diseases. A number of methods have been developed to detect CTCs, some of which have been applied in clinical diagnosis. However, conventional methods are restricted by invasiveness, lower sensitivity caused by small blood sample volumes, and difficulty in recording the dynamics of CTCs. A novel technique named
Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Zhi-Chao Fan,Jun Yan,Guang-Da Liu,Xiao-Ying Tan,Xiao-Fu Weng,Wei-Zhong Wu,Jian Zhou,Xun-Bin Wei

DOI: https://doi.org/10.1158/0008-5472.CAN-11-3733

IF: 11.2

2012-01-01

Cancer Research

Abstract:The fate of circulating tumor cells (CTC) is an important determinant of metastasis and recurrence, which leads to most deaths in hepatocellular carcinoma (HCC). Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying, and monitoring patients with metastatic diseases. In vivo flow cytometry has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and noninvasively. Here, we combine in vivo flow cytometry technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our in vivo flow cytometry has approximately 1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We found a significant difference in CTC dynamics between orthotopic and subcutaneous tumor models. We also investigated whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our results show that the number of CTCs and early metastases decreases significantly after the resection. The resection prominently restricts hematogenous metastasis and distant metastases. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel in vivo flow cytometry technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy. Cancer Res; 72(10); 2683-91. (C) 2012 AACR.
Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by In Vivo Flow Cytometry Assesses Resection on Metastasis

Zhi-Chao Fan,Jun Yan,Guang-Da Liu,Xiao-Ying Tan,Xiao-Fu Weng,Wei-Zhong Wu,Jian Zhou,Xun-Bin Wei

DOI: https://doi.org/10.1158/0008-5472.c.6502629

2023-01-01

Abstract:AbstractThe fate of circulating tumor cells (CTC) is an important determinant of metastasis and recurrence, which leads to most deaths in hepatocellular carcinoma (HCC). Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying, and monitoring patients with metastatic diseases. In vivo flow cytometry has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and noninvasively. Here, we combine in vivo flow cytometry technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our in vivo flow cytometry has approximately 1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We found a significant difference in CTC dynamics between orthotopic and subcutaneous tumor models. We also investigated whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our results show that the number of CTCs and early metastases decreases significantly after the resection. The resection prominently restricts hematogenous metastasis and distant metastases. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel in vivo flow cytometry technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy. Cancer Res; 72(10); 2683–91. ©2012 AACR.
In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Dan Wei,Zhichao Fan,Xueding Wang,Xunbin Wei

DOI: https://doi.org/10.1117/12.2003620

2013-01-01

Abstract:Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, with approximately 1,000,000 cases reported every year. The fate of circulating tumor cells (CTCs) is an important determinant of metastasis and recurrence, which lead to most deaths in HCC. Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying and monitoring patients with metastatic diseases. In vivo flow cytometry (IVFC) has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and non-invasively. Here, we combine IVFC technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our IVFC has ~1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We find out a significant difference of CTC dynamics between orthotopic and subcutaneous (s.c.) tumor models. We also investigate whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our result shows that the number of CTCs and early metastases decreases after the resection. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel IVFC technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy.
Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by in Vivo Flow Cytometry Assesses Resection on Metastasis

Zhichao Fan,Jun Yan,Guang-Da Liu,Xiao-Ying Tan,Xiaofu Weng,Wei‐Zhong Wu,Jing Zhou,Xunbin Wei

DOI: https://doi.org/10.1158/0008-5472.c.6502629.v1

2023-01-01

Abstract:AbstractThe fate of circulating tumor cells (CTC) is an important determinant of metastasis and recurrence, which leads to most deaths in hepatocellular carcinoma (HCC). Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying, and monitoring patients with metastatic diseases. In vivo flow cytometry has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and noninvasively. Here, we combine in vivo flow cytometry technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our in vivo flow cytometry has approximately 1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We found a significant difference in CTC dynamics between orthotopic and subcutaneous tumor models. We also investigated whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our results show that the number of CTCs and early metastases decreases significantly after the resection. The resection prominently restricts hematogenous metastasis and distant metastases. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel in vivo flow cytometry technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy. Cancer Res; 72(10); 2683–91. ©2012 AACR.
Real Time Monitoring of Daily Variation of Circulating Tumor Cells by in Vivo Flow Cytometry (conference Presentation)

Xi Zhu,Qi Liu,Xunbin Wei

DOI: https://doi.org/10.1117/12.2544813

2020-01-01

Abstract:Circulating tumor cells (CTCs) are considered as the “seeds” which disseminate from the solid tumors, circulate within the vasculature and colonize the distant organs (“soil”). CTCs level in peripheral blood has been used for diagnosis, staging, prognosis of cancer, as well as treatment evaluation. Currently, the ex vivo CTC isolation methods (e.g. CellSearch system) are limited to several milliliters of blood and do not take into account the temporal distribution of CTCs in the peripheral blood, However, few studies were conducted to investigate whether CTCs were released into the blood vessel erratically and whether the distribution of CTCs in the blood is uniform. A reliable research tool that can provide sufficient quantity of CTCs, as well as the temporal information of each CTC is necessary to study the temporal distribution of CTCs. In vivo flow cytometry (IVFC) has been demonstrated to be a powerful tool for real-time and continuous monitoring of circulating cells. The time points of each CTC events are recorded with IVFC detection. Here, we established an orthotopic mouse model of prostate cancer by using GFP labeled PC3 cell lines and monitored the variation of CTCs in mouse ear arteries during 24-h of a day with IVFC. Our results suggested that the temporal distribution of CTCs was not even in the orthotopic mouse model of prostate cancer and CTC release may be regulated by circadian rhythm. Our work is thus hopeful to provide a guideline on the time of blood sampling and gain insight into the shedding process of CTCs.
Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

Xi Zhu,Yuanzhen Suo,Nan Ding,Hao He,Xunbin Wei

DOI: https://doi.org/10.1364/pibm.2017.w3a.104

2017-01-01

Abstract:Tumor cells detached from primary tumor can invade vasculature and form circulating tumor cells (CTCs). Very few of CTCs could be arrested by capillaries. Subsequently, these cells extravasate into distant organs to seed new metastatic colonies. The prognostic significance of CTC numbers has been proved in many kinds of cancer. Even great efforts have been made in recent years to isolate CTCs from blood of patients, there are 36% of breast cancer patients with metastatic disease have undetectable CTCs. This may because that CTCs were not appeared at the sampling sites at the time of sampling. Therefore, understanding the distribution of CTCs may improve the detectable rate of it. In this work, we analyzed the temporal distribution of CTCs detected by in vivo flow cytometry (IVFC), which has been reported to be a powerful tool for monitoring CTCs continuously. We found CTCs were nonuniformly distributed in an orthotopic mouse model of human hepatocellular carcinoma, and we for the first time demonstrated that CTC intervals in late stages of cancer are exponential distribution and the number of CTCs occur within any time interval obeys Poisson distribution. Our study may give new insight into cancer metastasis process.
Monitoring circulating prostate tumor cells after tumor resection by in vivo flow cytometry

Nan Ding,Xi Zhu,Chengying Xie,Dan Wei,Zhangru Yang,Yuanzhen Suo,Xunbin Wei

DOI: https://doi.org/10.1117/12.2289997

2018-01-01

Abstract:Prostate cancer has already become the biggest threat among all cancer types for male people and many people died because of its bone metastases. Circulating tumor cells (CTCs) can be used as early metastasis marker so that the detection of CTCs in blood is meaningful for early diagnosis and treatment. However, the relationship between these therapies and metastasis has not been fully clarified yet. Hence, we built PC3 subcutaneous tumor model and developed in vivo flow cytometer (IVFC) platform to record the dynamics of CTC before and after tumor resection. We found out that tumor resection can reduce CTC quantities instantaneously while having a good control of metastasis. CTC re-occurred 7 days after surgery, which might be correlated with early disseminated and deposited tumors. In conclusion, in vivo flow cytometry (IVFC) is capable of detecting CTC dynamics in prostate subcutaneous tumor model and this method could facilitate further research about relationship between other cancer therapies and circulating tumor cells.
Advances of In Vivo Flow Cytometry on Cancer Studies

Yuanzhen Suo,Zhenqin Gu,Xunbin Wei

DOI: https://doi.org/10.1002/cyto.a.23851

IF: 4.714

2019-07-05

Cytometry Part A

Abstract:Cancer is a big threat to human life. Asia has about 60% of the global population and accounts for half of global cancer incidence and mortality. Circulating tumor cells (CTCs) have been a good biomarker for cancer diagnosis, staging, and prognosis. Conventional detection methods of CTCs require drawing blood. It may disturb the biological environment and limited real‐time monitoring. in vivo flow cytometry (IVFC) is a burgeoning technique that allows noninvasive detection of CTCs in vivo. Here, we review the technical development of IVFC based on various contrast principles, including fluorescence IVFC, photoacoustic IVFC, imaging IVFC, and label‐free IVFC. This powerful tool has been applied widely in many areas of cancer‐related studies, especially the CTC studies. We review applications of IVFC in preclinical studies on prevalent cancers in Asia, including liver cancer, blood cancer, and so forth. Other cancer‐related studies in breast cancer, prostate cancer, cancer‐related stem cell research and drug studies are also reviewed. © 2019 International Society for Advancement of Cytometry

cell biology,biochemical research methods
Algorithm to Identify Circulating Tumor Cell Clusters Using in Vivo Flow Cytometer

Kai Pang,Dan Wei,Pengfei Hai,Zhangru Yang,Xiaofu Weng,Xunbin Wei

DOI: https://doi.org/10.1142/s1793545818500244

2018-01-01

Abstract:Recent studies in oncology have addressed the importance of detecting circulating tumor cell clusters because circulating tumor cell clusters might survive and metastasize more easily than single circulating tumor cells. Signals with larger peak widths detected by in vivo flow cytometer (IVFC) have been used to identify cell clusters in previous studies. However, the accuracy of this criterion might be greatly degraded by variance in blood flow and the rolling behaviors of circulating tumor cells. Here, we propose a criterion and algorithm to distinguish cell clusters from single cells. In this work, we first used area-based and volume-based models for single fluorescent cells. Simulating each model, we analyzed the corresponding morphology of IVFC signals from cell clusters. According to the Rayleigh criterion, the valley between two adjacent peak signals from two distinguishable cells should be lower than 73.5% of the peak values. A novel signal processing algorithm for IVFC was developed based on this criterion. The results showed that cell clusters can be reliably identified using our proposed algorithm. Intravital imaging was also performed to further support our algorithm. With enhanced accuracy, IVFC is a powerful tool to study circulating cell clusters.
Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

Dan Wei,Xuejiao Zeng,Zhangru Yang,Quanyu Zhou,Xiaofu Weng,Hao He,Wenyuan Gao,Zhengqin Gu,Xunbin Wei

DOI: https://doi.org/10.1109/tbme.2019.2891068

IF: 4.6

2019-01-01

IEEE Transactions on Biomedical Engineering

Abstract:Objective: Visualizing cell interactions in blood circulation is of great importance in studies of anticancer immunotherapy or drugs. However, the lack of a suitable imaging system hampers progress in this field. Methods: In this work, we built a dual-channel in vivo imaging flow cytometer to visualize the interactions of circulating tumor cells (CTCs) and dendritic cells (DCs) simultaneously in the bloodstream. Two artificial neural networks were trained to identify blood vessels and cells in the acquired images. Results and Conclusion: Using this technique, single CTCs and CTC clusters were readily distinguished by their morphology. Interactions of CTCs and DCs were identified, while their moving velocities were analyzed. The CTC-DC clusters moved at a slower velocity than that of single CTCs or DCs. This may provide new insights into tumor metastasis and blood rheology. Significance: This in vivo imaging flow cytometry system holds great potential for assessing the efficiency of targeting CTCs with anticancer immune cells or drugs.
A Model for the Detection of Circulating Tumor Cells Based on Micro-OCT Imaging

Jinqian Lv,Chenlong Xue,Junfan Chen,Yaofei Jiang,Jiang Du,Junyu Wei,Hong Dang,Quan Tang,Han Wang,Hu Liang,Gina Jinna Chen,Xiaojun Yu,Yanqun Xiang,Perry Ping Shum

DOI: https://doi.org/10.1109/OGC59456.2023.10314642

2023-01-01

Abstract:Circulating tumor cells (CTCs) escape from the primary tumor site, then shed to the circulating system and travel around the body through the bloodstream before initiating metastatic tumors. However, CTCs in the circulatory system are rare, which makes it challenging to isolate and observe. Here, we aim to provide a feasible model to observe CTCs with high-resolution Optical Coherence Tomography (μOCT) in microfluidics, simulating the blood flow in vascular. CTCs are enriched and sorted by our microfluidic system. We obtained high-resolution CTCs' OCT images with the indication of fluorescent labeling for the data collection for real-time diagnostic system construction.
Studying leukemia metastasis by in vivo imaging and flow cytometer

Xunbin Wei,Yun Chen,Yan Li,Li Zhang,Guangda Liu

DOI: https://doi.org/10.1364/aoe.2008.sun3

2009-01-01

Abstract:A recently developed ldquoin vivo flow cytometerrdquo and optical imaging are used to assess leukemic cell spreading and the circulation kinetics, as well as assess the effectiveness of the potential therapeutic interventions.
Data from In Vivo Flow Cytometry

Irene Georgakoudi,Nicolas Solban,John Novak,William L. Rice,Xunbin Wei,Tayyaba Hasan,Charles P. Lin

DOI: https://doi.org/10.1158/0008-5472.c.6493608

2023-01-01

Abstract:<div>AbstractThe fate of circulating tumor cells is an important determinant of their ability to form distant metastasis. Here, we demonstrate the use of in vivo flow cytometry as a powerful new method for detecting quantitatively circulating cancer cells. We specifically examine the circulation kinetics of two prostate cancer cell lines with different metastatic potential in mice and rats. We find that the cell line and the host environment affect the circulation kinetics of prostate cancer cells, with the intrinsic cell line properties determining the initial rate of cell depletion from the circulation and the host affecting cell circulation at later time points.</div>

Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Monitoring Hepatocellular Carcinoma Metastasis by in Vivo Flow Cytometer

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

Monitoring circulating tumor cells in vivo by a confocal microscopy system

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Studying Cancer Metastasis Potential by In-Vivo Flow Cytometry and Imaging

Monitoring Circulating Apoptotic Cells by In-Vivo Flow Cytometry

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>In Vivo</i> Flow Cytometry Assesses Resection on Metastasis

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>in Vivo</i> Flow Cytometry Assesses Resection on Metastasis

Real Time Monitoring of Daily Variation of Circulating Tumor Cells by in Vivo Flow Cytometry (conference Presentation)

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

Monitoring circulating prostate tumor cells after tumor resection by in vivo flow cytometry

Advances of In Vivo Flow Cytometry on Cancer Studies

Algorithm to Identify Circulating Tumor Cell Clusters Using in Vivo Flow Cytometer

Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

A Model for the Detection of Circulating Tumor Cells Based on Micro-OCT Imaging

Studying leukemia metastasis by in vivo imaging and flow cytometer

Data from <b><i>In Vivo</i></b> Flow Cytometry

Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Monitoring Hepatocellular Carcinoma Metastasis by in Vivo Flow Cytometer

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

Monitoring circulating tumor cells in vivo by a confocal microscopy system

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Studying Cancer Metastasis Potential by In-Vivo Flow Cytometry and Imaging

Monitoring Circulating Apoptotic Cells by In-Vivo Flow Cytometry

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>In Vivo</i> Flow Cytometry Assesses Resection on Metastasis

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by &lt;i&gt;in Vivo&lt;/i&gt; Flow Cytometry Assesses Resection on Metastasis

Real Time Monitoring of Daily Variation of Circulating Tumor Cells by in Vivo Flow Cytometry (conference Presentation)

Circulating tumor cells occur nonuniformly monitored by in vivo flow cytometry

Monitoring circulating prostate tumor cells after tumor resection by in vivo flow cytometry

Advances of In Vivo Flow Cytometry on Cancer Studies

Algorithm to Identify Circulating Tumor Cell Clusters Using in Vivo Flow Cytometer

Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

A Model for the Detection of Circulating Tumor Cells Based on Micro-OCT Imaging

Studying leukemia metastasis by in vivo imaging and flow cytometer

Data from &lt;b&gt;&lt;i&gt;In Vivo&lt;/i&gt;&lt;/b&gt; Flow Cytometry

Data from Real-Time Monitoring of Rare Circulating Hepatocellular Carcinoma Cells in an Orthotopic Model by <i>in Vivo</i> Flow Cytometry Assesses Resection on Metastasis

Data from <b><i>In Vivo</i></b> Flow Cytometry